Armand, P., Gannamaneni, S., Kim, H. T., Cutler, C. S., Ho, V. T., Koreth, J., . . . Antin, J. H. (2008). Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning. American Society of Clinical Oncology.
Chicago ZitierstilArmand, Philippe, et al. Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning. American Society of Clinical Oncology, 2008.
MLA ZitierstilArmand, Philippe, et al. Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning. American Society of Clinical Oncology, 2008.